Tag: ECTRIMS
GeNeuro – Presentation of new data at ECTRIMS 2025 in Copenhagen showing the repair of neurodegenerative effects of HERV-W by Temelimab in a model of MS – 09/19/2024 at 6:30 p.m.
[ad_1] Geneva, Switzerland, September 19, 2024 – 6:30 PM CEST – GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company focused on addressing the drivers of neurodegenerative and autoimmune diseases,…